Clinical Trial Update: MW151 and Whole-brain Radiotherapy in Patients With Intracranial Metastases [Phase 1]

View source ↗

Summary

Phase 1 trial update of MW151 in combination with whole-brain radiotherapy for patients with brain metastases, focusing on cognitive outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• MW151

Snippet

Sponsor: ImmunoChem Therapeutics, LLC | Conditions: Cognitive Dysfunction, Cognitive Disorder | Phase 1 | Status: COMPLETED